Salud financiera de hoja de balance de Sinocare

Salud financiera controles de criterios 5/6

Sinocare tiene un patrimonio de accionistas total de CN¥3.6B y una deuda total de CN¥981.8M, lo que sitúa su ratio deuda-patrimonio en 27.5%. Sus activos y pasivos totales son CN¥5.9B y CN¥2.4B respectivamente. El BAIT de Sinocare es de CN¥385.7M, por lo que su ratio de cobertura de intereses es de 13.5. Tiene efectivo e inversiones a corto plazo que ascienden a CN¥845.4M.

Información clave

27.5%

Ratio deuda-patrimonio

CN¥981.81m

Deuda

Ratio de cobertura de intereses	13.5x
Efectivo	CN¥845.42m
Patrimonio	CN¥3.58b
Total pasivo	CN¥2.36b
Activos totales	CN¥5.93b

Actualizaciones recientes sobre salud financiera

Is Sinocare (SZSE:300298) Using Too Much Debt?

Nov 17

Is Sinocare (SZSE:300298) A Risky Investment?

Jun 07

Recent updates

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo (CN¥2.2B) de 300298 superan a sus pasivos a corto plazo (CN¥1.6B).

Pasivo a largo plazo: Los activos a corto plazo de 300298 (CN¥2.2B) superan a sus pasivos a largo plazo (CN¥797.1M).

Historial y análisis de deuda-patrimonio

Nivel de deuda: El ratio deuda neta-patrimonio (3.8%) de 300298 se considera satisfactorio.

Reducción de la deuda: El ratio deuda-patrimonio de 300298 ha crecido de 5.9% a 27.5% en los últimos 5 años.

Cobertura de la deuda: La deuda de 300298 está bien cubierta por el flujo de caja operativo (74.2%).

Cobertura de intereses: Los pagos de intereses de la deuda de 300298 están bien cubiertos por el BAIT (13.5x cobertura).

Salud financiera de hoja de balance de Sinocare

Salud financiera controles de criterios 5/6

Información clave

Actualizaciones recientes sobre salud financiera

Is Sinocare (SZSE:300298) Using Too Much Debt?

Is Sinocare (SZSE:300298) A Risky Investment?

Recent updates

Is Sinocare (SZSE:300298) Using Too Much Debt?

We Think You Can Look Beyond Sinocare's (SZSE:300298) Lackluster Earnings

Consensus EPS estimates fall by 11%

New minor risk - Profit margin trend

Estimating The Intrinsic Value Of Sinocare Inc. (SZSE:300298)

Investor sentiment deteriorates as stock falls 15%

Sinocare (SZSE:300298) Is Reinvesting At Lower Rates Of Return

New minor risk - Share price stability

Sinocare Inc. to Report Q3, 2024 Results on Oct 24, 2024

Now 21% overvalued after recent price rise

Investor sentiment improves as stock rises 15%

Second quarter 2024 earnings released: EPS: CN¥0.21 (vs CN¥0.19 in 2Q 2023)

Sinocare Inc.'s (SZSE:300298) Price Is Out Of Tune With Earnings

Calculating The Intrinsic Value Of Sinocare Inc. (SZSE:300298)

Sinocare Inc. to Report First Half, 2024 Results on Aug 29, 2024

Sinocare Inc. Announces Dividend Implementation for 2023, Payable on 17 June 2024

Is Sinocare (SZSE:300298) A Risky Investment?

Sinocare's (SZSE:300298) Soft Earnings Don't Show The Whole Picture

Price target decreased by 8.0% to CN¥31.01

Sinocare Inc., Annual General Meeting, May 21, 2024

Sinocare Inc. Proposes Final Dividend for 2023

First quarter 2024 earnings released: EPS: CN¥0.15 (vs CN¥0.12 in 1Q 2023)

Investor sentiment improves as stock rises 16%

Sinocare Inc.'s (SZSE:300298) P/E Is On The Mark

Now 21% undervalued after recent price drop

Here's What To Make Of Sinocare's (SZSE:300298) Decelerating Rates Of Return

Sinocare Inc. to Report Q1, 2024 Results on Apr 26, 2024

Now 21% undervalued after recent price drop

Investor sentiment deteriorates as stock falls 16%

Sinocare Inc. to Report Fiscal Year 2023 Results on Apr 26, 2024

Investor sentiment improves as stock rises 24%

Third quarter 2023 earnings released: EPS: CN¥0.26 (vs CN¥0.28 in 3Q 2022)

Now 20% undervalued

Sinocare Inc. to Report Q3, 2023 Results on Oct 24, 2023

Now 20% undervalued after recent price drop

Price target decreased by 14% to CN¥33.71

Second quarter 2023 earnings released: EPS: CN¥0.19 (vs CN¥0.26 in 2Q 2022)

Sinocare Inc. (SZSE:300298) announces an Equity Buyback for CNY 150 million worth of its shares.

Sinocare Inc. (SZSE:300298) announces an Equity Buyback for CNY 150 million worth of its shares.

Now 21% undervalued after recent price drop

Investor sentiment improves as stock rises 17%

Sinocare Inc. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 26 May 2023

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Price target increased to CN¥39.34

Sinocare Inc. Approves Board Elections

Investor sentiment improved over the past week

Third quarter 2022 earnings released: EPS: CN¥0.28 (vs CN¥0.14 in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.26 (vs CN¥0.13 in 2Q 2021)

Sinocare Inc. Approves Cash Dividend for the Year 2021

Investor sentiment improved over the past week

Consensus forecasts updated

Price target decreased to CN¥20.73

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

High number of new directors

Sinocare Inc., Annual General Meeting, May 13, 2022

Sinocare Inc. Proposes Cash Dividend for 2021

Third quarter 2021 earnings released: EPS CN¥0.14 (vs CN¥0.16 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.13 (vs CN¥0.17 in 2Q 2020)

Price target decreased to CN¥40.66

Consensus forecasts updated

First quarter 2021 earnings released: EPS CN¥0.079 (vs CN¥0.11 in 1Q 2020)

Investor sentiment deteriorated over the past week

New 90-day low: CN¥31.87

Sinocare Inc. to Report Fiscal Year 2020 Results on Apr 17, 2021

New 90-day high: CN¥46.30

Third quarter earnings released

Sinocare Inc. to Report Q3, 2020 Results on Oct 17, 2020

Earnings released

Sinocare Inc. to Report First Half, 2020 Results on Aug 07, 2020

Análisis de la situación financiera

Historial y análisis de deuda-patrimonio

Hoja de balance

Descubre empresas con salud financiera